(NASDAQ: IOSP) Innospec's forecast annual revenue growth rate of 2.53% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 10.55%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,351.34%.
Innospec's revenue in 2025 is $1,790,700,000.On average, 5 Wall Street analysts forecast IOSP's revenue for 2025 to be $45,593,683,596, with the lowest IOSP revenue forecast at $43,408,365,428, and the highest IOSP revenue forecast at $47,406,504,349.
In 2026, IOSP is forecast to generate $48,846,827,687 in revenue, with the lowest revenue forecast at $46,438,011,070 and the highest revenue forecast at $51,230,811,143.